Page last updated: 2024-08-23

dermatan sulfate and Brain Vascular Disorders

dermatan sulfate has been researched along with Brain Vascular Disorders in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	6 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Büller, HR; Henny, CP; Magnani, HN; Ten Cate, H; Ten Cate, JW	1
Turpie, AG	1
Adams, HP; Bendixen, BH; Clarke, WR; Davis, PH; Grimsman, KJ; Love, BB; Wasek, PA; Woolson, RF	1
Adams, HP; Bendixen, BH; Chang, KC; Clarke, WR; Davis, PH; Hansen, MD; Leira, EC; Woolson, RF	1
Adams, HP; Chaturvedi, S; Woolson, RF	1
Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM	1
Adams, HP; Alberts, M; Biller, J; Bruno, A; Davis, JN; Goldstein, LB; Marler, JR; Massey, EW	1
Andrew, M; Carter, CJ; Gent, M; Hirsh, J; Hull, RD; Jay, RM; Levine, MN; Magnani, HN; Powers, PJ; Turpie, AG	1
Adams, HP; Alberts, M; Biller, J; Bruno, A; Davis, JN; Goldstein, LB; Henriksen, RA; Linhardt, RJ; Marler, JR; Massey, EW	1

Reviews

1 review(s) available for dermatan sulfate and Brain Vascular Disorders

Article	Year
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2 Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis	1991

Article

Year

Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.

Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2

Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis

1991

Trials

4 trial(s) available for dermatan sulfate and Brain Vascular Disorders

Article	Year
Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Controlled clinical trials, 1997, Volume: 18, Issue:4 Topics: Adult; Aged; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Male; Middle Aged; Research Design; Treatment Outcome	1997
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology, 1999, Jul-13, Volume: 53, Issue:1 Topics: Anticoagulants; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Female; Follow-Up Studies; Glasgow Coma Scale; Heparitin Sulfate; Humans; Male; National Institutes of Health (U.S.); Probability; Time Factors; Trauma Severity Indices; Treatment Outcome; United States	1999
Circadian variation in ischemic stroke subtypes. Stroke, 1999, Volume: 30, Issue:9 Topics: Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Chondroitin Sulfates; Circadian Rhythm; Dermatan Sulfate; Forecasting; Heparitin Sulfate; Humans	1999
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (London, England), 1987, Mar-07, Volume: 1, Issue:8532 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Radiography; Random Allocation; Thrombosis; Time Factors	1987

Other Studies

4 other study(ies) available for dermatan sulfate and Brain Vascular Disorders

Article	Year
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease. Annals of neurology, 1984, Volume: 15, Issue:3 Topics: Aged; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparitin Sulfate; Humans; Male; Middle Aged; Thromboembolism	1984
Prophylaxis of venous thromboembolism in stroke patients. Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:2 Topics: Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombophlebitis	1997
Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke, 1990, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Intravenous; Middle Aged; Pilot Projects	1990
A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Neurology, 1989, Volume: 39, Issue:2 Pt 1 Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Molecular Weight	1989